Article Text

Download PDFPDF
Dabigatran in the setting of catheter ablation of atrial fibrillation: the road ahead

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors RP has prepared the response to the letter which was revised and completed with suggestions of the three remaining authors. All authors approved the final version.

  • Competing interests RP has received honoraria for serving as a speaker and consultant for Boheringher-Ingelheim and as a co-investigator in the ENGAGE-AF TIMI 48 trial. There are no conflicts of interest by other coauthors.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles